ERBB2 and breast carcinoma: HER2-positive breast cancer has a better prognosis, which is mainly due to the effective treatment of HER2-positive breast cancer with surgery, radiotherapy and chemotherapy, endocrine therapy, molecular targeted therapy, and other treatments (7).